What is CBD?
Cannabidiol (CBD) is a type of cannabinoid, a natural chemical compound found in cannabis plants that interacts with the endocannabinoid biological system in humans and other mammals. The endocannabinoid system regulates various cognitive and physiological processes – such as mood, sleep, appetite, and pain-sensation – in order to promote homeostasis, or equilibrium in the body. When introduced into the body, CBD and other cannabinoids assist with regulation and homeostasis, which can help alleviate pain, improve sleep quality, regulate appetite, and reduce stress.
How much CBD should I take?
There are a lot of variables that go into deciding how much CBD to take. Before trying CBD, be sure to talk to your doctor about an appropriate dosage and any potential risks. If your doctor tells you how much to use, stick to their recommendation. If your doctor doesn’t provide a recommendation, it’s best to start with a smaller dosage and gradually increase it.
Am I taking 500mg of CBD if I take a dropper fulL of tincture?
The answer is No. each 1-mL serving will contain approximately 16.67 mg of CBD; you are not ingesting 500 mg with each dosage. Typically a dropper holds 1 ML of liquiD
What is difference between marijuana and hemp?
Although marijuana and hemp can both come from the cannabis sativa family, they're distinctly different. Marijuana is bushier with broader leaves, while hemp is leaner with shinier leaves. It's differences in their chemical composition that really set them apart, though. More than 100 chemical cannabinoids are found in cannabis, but the amount of these cannabinoids differs dramatically between hemp and marijuana. Marijuana's most common cannabinoid is tetrahydrocannabinol (THC) -- the chemical cannabinoid associated with the plant's psychoactive effect. In marijuana, THC levels can reach 30%, depending on the strain, but THC levels in hemp are less than 0.3%. Although hemp won't get you high, it does contain significant amounts of another cannabinoid, cannabidiol (CBD), which is also found in marijuana. CBD is a non-psychoactive cannabinoid, and its interaction with receptors in the central nervous system and immune system can offer medicinal benefits.
*All of our products are made with Hemp-derived CBD extract, which may contain small amounts of THC (< 0.3% legal limit in United States.)
*All topical application products are THC-free
Will CBD get me high?
CBD isn’t psychoactive — meaning it won’t get you “high.” Instead, research suggests that it may help:
reduce anxiety and depression
improve sleep
reduce seizures in people with epilepsy
soothe pain and inflammation
improve heart health
improve symptoms of inflammatory bowel disease (IBD)
What is CBG?
Starting with some of the similarities, both CBD and CBG act on the endocannabinoid system, and share a wide array of potential benefits. For example, cannabinoids have exhibited antimicrobial, anti-inflammatory, and anti-oxidant properties in a wide array of studies. On top of that, both CBG and CBD mediate the psychotropic effect of THC, i.e. they reduce the “high”. And they have both been observed to participate in the entourage effect, magnifying the therapeutic effect of each one when administered together.
An advantage that CBG has over CBD is the way it interacts with the endocannabinoid system. While CBD’s ability to directly interact with the brain’s cannabinoid receptors is limited, CBG binds directly to the CB1 and CB2 receptors and provides more direct effects to the system.
Outside of their organic properties, CBG is much harder to extract and produce than CBD. Due to the scarcity of CBG in the cannabis plant, its production is a much more expensive and often more delicate process. Most companies choose to focus on the extraction of CBD isolate, making CBG products comparatively rare and much more expensive.
While CBG first appeared in literature in 1964, it hasn’t been as thoroughly researched as the more abundant cannabinoids. But still, there have been numerous reports about the potential benefits of CBG.
One of the earliest papers to study CBG in comparison to other cannabinoids (1984) observed that THC, CBD, and CBG had a positive effect on intraocular tension. But unlike CBD and THC, CBG did not cause conjunctival erythema and hyperemia, making it a preferable treatment.
CBG, as well as other cannabinoids, has been shown to posess antimicrobial properties, and exhibited “potent activity against a variety of methicillin-resistant Staphylococcus aureus (MRSA)” in a 2008 study. These cannabinoids have been also shown to have analgesic or anti-inflammatory properties, and have shown a lot of promise when it comes to treating pain.
A 2018 study investigated the binding properties of CBG to cannabinoid CB1 (CB1R) and CB2 (CB2R) receptors and reported that CBG “may exert beneficial actions with therapeutic potential”.
A recent (January 2020) study found that CBG exhibits antibiotic properties against drug-resistant bacteria. Researchers used CBG to treat mice infected with MRSA (methicillin-resistant Staphylococcus aureus) and observed a similar level of in vivo efficacy to vancomycin which was used as the antibiotic control.
CBG has also shown potential when it comes to treating inflammatory bowel disease (IBD), alleviating inflammation in multiple sclerosis, protecting the nerves in Huntington’s Disease, and inhibiting the growth of carcinogenic cells in the colon.
FDA Disclosure
The statements on this website have not been evaluated by the Food and Drug Administration. The FDA has not evaluated any of these products and they are not intended for use to diagnose, treat, cure or prevent any disease or medical condition. These products are not intended for sale to persons under the age of 18. Before using any CBD products it is recommended that you conduct your own research and consult your health professionals to determine if they are suitable for your purposes.